Shenzhen Yhlo Biotech Co., Ltd. (688575.SH) announced that it has recently received the IVDR CE Class D certification, the highest risk level, issued by BSI Group The Netherlands B.V. The certified product is the iFlash-HIV Combo Human Immunodeficiency Virus Antigen and Antibody Detection Kit (Chemiluminescence Method), designed for qualitative detection of HIV p24 antigen and HIV-1/HIV-2 antibodies in human serum or plasma. This kit aids in the diagnosis of HIV infection and is also used for blood donation screening.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments